Biorelate
Literature-mined cause-and-effect data linking drugs, genes and diseases, for drug discovery and bioinformatics teams
Highlights
- Hiring2 open roles
- New on EvolcAdded 2026-10-30
- Remote-friendly2 of 2 open roles remote or hybrid
About Biorelate
Biorelate develops Galactic AI, which uses NLP models to extract cause-and-effect relationships between drugs, genes and diseases from biomedical publications, patents and trial records and organises them into a knowledge graph. Each relationship is typed, directional, resolved to a public identifier and linked to its source sentence. Outputs are available as downloadable files, through an API and MCP server, and in a web workspace.
Customers are drug discovery, data science and biology teams, including biotech and pharmaceutical companies. Stated use cases include target identification and prioritisation, biomarker discovery and early target safety assessment.
Biorelate was founded in 2014 as a PhD spinout from the University of Manchester and is headquartered in Manchester, UK. The company received investment in 2018 and 2022 and describes itself as a Series A company. It is fully remote and lists open roles on its careers page.
Product: Galactic AI, a causal evidence layer of drug-gene-disease relationships extracted from biomedical literature, accessed via data download, API, MCP and web.
Jobs at Biorelate (2)
Biorelate is hiring for 2 roles in customer support and sales. All are remote.
Sales Development Representative (SDR)
New on EvolcRemote-friendlyCustomer Success Manager
New on EvolcRemote-friendly
Companies hiring like Biorelate
Leadership
- Daniel Jamieson · CEO & FounderSource: company website
- Robert Correa · Vice President of SalesSource: company website
- Tom Todd · Vice President of TechnologySource: company website
More biotech & pharma companies
Biorex Diagnostics
In vitro diagnostic tests and reagents for hospitals, clinics, blood banks and research facilitiesNew on EvolcBlue Earth Diagnostics
Develops and commercialises PET molecular imaging agents for cancer and cardiology, used by clinicians and patientsNew on EvolcSalary transparentBlue Earth Therapeutics
Clinical-stage radiopharmaceutical developer targeting prostate cancer with PSMA-targeted radiohybrid therapiesNew on EvolcBounce Biomedical
Develops regenerative implants for patients with cartilage and bone injuries in jointsNew on EvolcBridge Farm Bioscience
Develops and manufactures plant-derived ingredients and extracts for pharmaceutical, nutraceutical and personal care businessesNew on EvolcC4X Discovery Holdings
Discovers small molecule drugs for immuno-inflammatory diseases, with partnered programmes at Sanofi and AstraZenecaNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Cloudflare
- Google Analytics 4
- Google reCAPTCHA
- Hotjar
- HubSpot
- Pinpoint
- Smartlook
- Webflow